论文部分内容阅读
Bone morphogenetic protein-2 (BMP-2) is considered a promising adjuvant for the treatment of skeletal non-union and spinal fusion.However, BMP-2 delivery in a conventional collagen scaffold necessitates a high dose to achieve an efficacious outcome.